Treatment-emergent Adverse Events Reported with Flubentylosin in Part 1 (Single Ascending Doses), presented by System-organ Class.
EVENTS
Subjects are counted only once in each row, regardless of how many events they experienced.In Part 2 (food effect), 58.3% of flubentylosin-treated subjects (66.7% under fasting and 50.0% under fed conditions) experienced at least one TEAE (